- Home
- RLMD vs NTIC Comparison
RLMD vs NTIC Comparison
Compare RLMD & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- NTIC
- Stock Information
- Founded
- RLMD 2004
- NTIC 1970
- Country
- RLMD United States
- NTIC United States
- Employees
- RLMD N/A
- NTIC N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- NTIC Industrial Specialties
- Sector
- RLMD Health Care
- NTIC Industrials
- Exchange
- RLMD Nasdaq
- NTIC Nasdaq
- Market Cap
- RLMD 110.6M
- NTIC 116.9M
- IPO Year
- RLMD N/A
- NTIC N/A
- Fundamental
- Price
- RLMD $2.75
- NTIC $14.24
- Analyst Decision
- RLMD Hold
- NTIC Buy
- Analyst Count
- RLMD 2
- NTIC 1
- Target Price
- RLMD $7.50
- NTIC $20.00
- AVG Volume (30 Days)
- RLMD 126.6K
- NTIC 16.6K
- Earning Date
- RLMD 11-07-2024
- NTIC 11-19-2024
- Dividend Yield
- RLMD N/A
- NTIC 2.00%
- EPS Growth
- RLMD N/A
- NTIC 83.33
- EPS
- RLMD N/A
- NTIC 0.55
- Revenue
- RLMD N/A
- NTIC $85,059,517.00
- Revenue This Year
- RLMD N/A
- NTIC $7.49
- Revenue Next Year
- RLMD N/A
- NTIC $11.52
- P/E Ratio
- RLMD N/A
- NTIC $25.20
- Revenue Growth
- RLMD N/A
- NTIC 6.45
- 52 Week Low
- RLMD $1.88
- NTIC $10.08
- 52 Week High
- RLMD $7.22
- NTIC $19.63
- Technical
- Relative Strength Index (RSI)
- RLMD 23.58
- NTIC 62.29
- Support Level
- RLMD $2.96
- NTIC $13.27
- Resistance Level
- RLMD $3.43
- NTIC $15.09
- Average True Range (ATR)
- RLMD 0.21
- NTIC 0.74
- MACD
- RLMD -0.07
- NTIC 0.09
- Stochastic Oscillator
- RLMD 1.60
- NTIC 68.16
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.